Abiraterone Tablets
Abiraterone Tablets is a oncology medication containing Abiraterone, available as 250mg tablets.
- Category
- Oncology
- Active ingredient
- Abiraterone
- Route
- Oral use
- Form
- Tablet, Film-coated tablet
- Strengths
- 250mg
You will receive a quality generic, depending on stock.
Prescription rules on Abiraterone Tablets vary by country.
Details
- Conditions
- Prostate cancer
- Alternative Name
- Zytiga
- Therapeutic Class
- Antiandrogen
- Pharmacological Class
- CYP17A1 Inhibitor
- Minor Side Effects
- oedema, fatigue, hypertension
- Moderate Side Effects
- hypokalaemia, elevated liver enzymes
- Dosage Forms
- Tablet, Film-coated tablet
- Administration Route
- Oral use
- Prescription Status
- Prescription medicine
- Originator
- Janssen-Cilag
- Onset Time
- 2 hours
- Duration
- 24 hours
- Storage Instructions
- Store below 30°C.
- Drug Interactions
- corticosteroids, CYP3A4 inducers
- Age Restrictions
- Not for use in women or children.
What you will receive
Abiraterone Tablets is a generic medicine sold under the name of its active ingredient, Abiraterone, rather than under a brand.
- You receive a quality generic; the exact manufacturer depends on what is in stock at the dispatching warehouse.
- It contains the same active ingredient as the brand-name versions, at the same dose, by regulatory standard.